| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_733bc45366649dfe8ce9772f4306ca76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a830f4fe37ddf1fb0670fe60aae075fd |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-06 |
| filingDate |
2002-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b367f4c48d1a4b1d444aedc48495bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c21b0e460d7011a090774a25efbe6f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4877150ac5d130e27e0aeb956e9427e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08a500af196893a02538a20e6ac3fdb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e10213a4e898d45428e7d2b47821f8 |
| publicationDate |
2004-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004003912-A |
| titleOfInvention |
Reagent for diagnosing active tuberculosis / active mycobacteriosis, test plate to which this reagent is fixed, and method of diagnosing active tuberculosis / active mycobacteriosis using these reagents |
| abstract |
[PROBLEMS] To be able to diagnose active tuberculosis and active MAC disease in a short time with a simple operation inspection, and to perform screening tests for mass infections, etc., confirmation of treatment effects, and other treatment stops or discharges. To provide the market with reagent kits that contribute to diagnosis such as determination. SOLUTION: 1) M.P. TDM-T separated and purified from Bovis BCG Tokyo strain. 2) M.P. TMM-T separated and purified from Bovis BCG Tokyo strain. 3) M.P. TMM-I separated and purified from Avivium Complex (MAC). 4) PL-2 isolated and adjusted from Mycobacterium tuberculosis 5) M.P. GPL-core prepared by removing a serotype-specific sugar chain of GPL antigen prepared from Abidium complex. A reagent for diagnosing active tuberculosis and active mycobacteriosis, wherein each of the above antigens is separately and independently included as a kit. [Selection diagram] Fig. 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115902217-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10782293-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11162944-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017032588-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019250160-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018231547-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017025757-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017025758-A1 |
| priorityDate |
2002-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |